A December 4, 2020, update to the FDA’s policy on conducting clinical trials during the current public health emergency is now available. While we haven’t read all 38 single-spaced pages of it, we notice it contains information useful to our research community, such as guidance about informed consent options, and adapting study procedures to minimize risks to study participants and staff. While this guidance is specific to FDA-regulated research, some of its content will be valuable to anyone involved in research that involves interaction with subjects.